162 related articles for article (PubMed ID: 33102492)
1. Base Editing Mediated Generation of Point Mutations Into Human Pluripotent Stem Cells for Modeling Disease.
Qi T; Wu F; Xie Y; Gao S; Li M; Pu J; Li D; Lan F; Wang Y
Front Cell Dev Biol; 2020; 8():590581. PubMed ID: 33102492
[TBL] [Abstract][Full Text] [Related]
2. Base Editing of Human Pluripotent Stem Cells for Modeling Long QT Syndrome.
Wu F; Guo T; Sun L; Li F; Yang X
Stem Cell Rev Rep; 2022 Apr; 18(4):1434-1443. PubMed ID: 34997921
[TBL] [Abstract][Full Text] [Related]
3. Transition Substitution of Desired Bases in Human Pluripotent Stem Cells with Base Editors: A Step-by-Step Guide.
Park JC; Kim KT; Jang HK; Cha HJ
Int J Stem Cells; 2023 May; 16(2):234-243. PubMed ID: 36823978
[TBL] [Abstract][Full Text] [Related]
4. BIG-TREE: Base-Edited Isogenic hPSC Line Generation Using a Transient Reporter for Editing Enrichment.
Brookhouser N; Tekel SJ; Standage-Beier K; Nguyen T; Schwarz G; Wang X; Brafman DA
Stem Cell Reports; 2020 Feb; 14(2):184-191. PubMed ID: 32004495
[TBL] [Abstract][Full Text] [Related]
5. High expression of uracil DNA glycosylase determines C to T substitution in human pluripotent stem cells.
Park JC; Jang HK; Kim J; Han JH; Jung Y; Kim K; Bae S; Cha HJ
Mol Ther Nucleic Acids; 2022 Mar; 27():175-183. PubMed ID: 34976436
[TBL] [Abstract][Full Text] [Related]
6. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
[TBL] [Abstract][Full Text] [Related]
7. Efficient Generation of Pathogenic A-to-G Mutations in Human Tripronuclear Embryos via ABE-Mediated Base Editing.
Li G; Liu X; Huang S; Zeng Y; Yang G; Lu Z; Zhang Y; Ma X; Wang L; Huang X; Liu J
Mol Ther Nucleic Acids; 2019 Sep; 17():289-296. PubMed ID: 31279230
[TBL] [Abstract][Full Text] [Related]
8. Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes.
Paci M; Casini S; Bellin M; Hyttinen J; Severi S
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428582
[TBL] [Abstract][Full Text] [Related]
9. Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells.
Li M; Zhong A; Wu Y; Sidharta M; Beaury M; Zhao X; Studer L; Zhou T
Nat Commun; 2022 Oct; 13(1):6354. PubMed ID: 36302757
[TBL] [Abstract][Full Text] [Related]
10. Development of a universal antibiotic resistance screening reporter for improving efficiency of cytosine and adenine base editing.
Ma L; Xing J; Li Q; Zhang Z; Xu K
J Biol Chem; 2022 Jul; 298(7):102103. PubMed ID: 35671823
[TBL] [Abstract][Full Text] [Related]
11. Multiple isogenic GNE-myopathy modeling with mutation specific phenotypes from human pluripotent stem cells by base editors.
Park JC; Kim J; Jang HK; Lee SY; Kim KT; Kwon EJ; Park S; Lee HS; Choi H; Park SY; Choi HJ; Park SJ; Moon SH; Bae S; Cha HJ
Biomaterials; 2022 Mar; 282():121419. PubMed ID: 35202935
[TBL] [Abstract][Full Text] [Related]
12. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.
Ban K; Bae S; Yoon YS
Theranostics; 2017; 7(7):2067-2077. PubMed ID: 28638487
[TBL] [Abstract][Full Text] [Related]
13. A robust and inducible precise genome editing via an all-in-one prime editor in human pluripotent stem cells.
Wu Y; Zhong A; Sidharta M; Kim TW; Ramirez B; Persily B; Studer L; Zhou T
bioRxiv; 2024 Jan; ():. PubMed ID: 38293122
[TBL] [Abstract][Full Text] [Related]
14. Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.
Abilez OJ; Tzatzalos E; Yang H; Zhao MT; Jung G; Zöllner AM; Tiburcy M; Riegler J; Matsa E; Shukla P; Zhuge Y; Chour T; Chen VC; Burridge PW; Karakikes I; Kuhl E; Bernstein D; Couture LA; Gold JD; Zimmermann WH; Wu JC
Stem Cells; 2018 Feb; 36(2):265-277. PubMed ID: 29086457
[TBL] [Abstract][Full Text] [Related]
15. Application of human pluripotent stem cells and pluripotent stem cell-derived cellular models for assessing drug toxicity.
Apáti Á; Varga N; Berecz T; Erdei Z; Homolya L; Sarkadi B
Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):61-75. PubMed ID: 30526128
[No Abstract] [Full Text] [Related]
16. Gene editing with 'pencil' rather than 'scissors' in human pluripotent stem cells.
Park JC; Park MJ; Lee SY; Kim D; Kim KT; Jang HK; Cha HJ
Stem Cell Res Ther; 2023 Jun; 14(1):164. PubMed ID: 37340491
[TBL] [Abstract][Full Text] [Related]
17. The generation of induced pluripotent stem cells from a patient with KCNH2 G603D, without LQT2 disease associated symptom.
Okata S; Yuasa S; Yamane T; Furukawa T; Fukuda K
J Med Dent Sci; 2013 Mar; 60(1):17-22. PubMed ID: 23917959
[TBL] [Abstract][Full Text] [Related]
18. An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells.
Xie Y; Wang D; Lan F; Wei G; Ni T; Chai R; Liu D; Hu S; Li M; Li D; Wang H; Wang Y
Sci Rep; 2017 May; 7(1):2320. PubMed ID: 28539611
[TBL] [Abstract][Full Text] [Related]
19. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
Jouni M; Si-Tayeb K; Es-Salah-Lamoureux Z; Latypova X; Champon B; Caillaud A; Rungoat A; Charpentier F; Loussouarn G; Baró I; Zibara K; Lemarchand P; Gaborit N
J Am Heart Assoc; 2015 Sep; 4(9):e002159. PubMed ID: 26330336
[TBL] [Abstract][Full Text] [Related]
20. Chemical-defined and albumin-free generation of human atrial and ventricular myocytes from human pluripotent stem cells.
Pei F; Jiang J; Bai S; Cao H; Tian L; Zhao Y; Yang C; Dong H; Ma Y
Stem Cell Res; 2017 Mar; 19():94-103. PubMed ID: 28110125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
